Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hui Liu
Observed name:
Liu, Hui
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Second Affiliated Hospital of Zhejiang University,
First Affiliated Hospital Zhejiang University,
Zhejiang University
ORCID:
0000-0003-1452-5062
Observed ORCID:
0000-0003-1452-5062
OpenAlex ID:
A5004230277
CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma
2020
·
Hui Liu
, Wen Lei
, et al.
·
Clinical Cancer Research
·
160
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial
2025
·
Wen Lei
, Hui Liu
, et al.
·
Nature Cancer
·
88
CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy
2024
·
Shanshan Guo
, Wen Lei
, et al.
·
Blood Advances
·
48
PDF
Incidence and prophylaxis of herpes zoster in relapsed or refractory B-cell lymphoma patients after CD19-specific CAR-T cell therapy
2021
·
Hui Liu
, Ping Li
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
9
Author Correction: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial
2025
·
Wen Lei
, Hui Liu
, et al.
·
Nature Cancer
·
5
PDF
Outcomes and risk factors of SARS‐CoV ‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy
2023
·
Xibin Xiao
, Panpan Chen
, et al.
·
Cancer Medicine
·
3
PDF
Data from CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma
2023
·
Hui Liu
, Wen Lei
, et al.
Data from CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma
2023
·
Hui Liu
, Wen Lei
, et al.
Supplementary Data from CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma
2023
·
Hui Liu
, Wen Lei
, et al.
Supplementary Data from CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma
2023
·
Hui Liu
, Wen Lei
, et al.
Supplementary Data from CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma
2023
·
Hui Liu
, Wen Lei
, et al.
Show more works
View as search
Works count:
13
Citation count:
313
H-index:
5
I10-index:
3
Year
Topic
Type